Category «Uncategorized»

Brivudine

Brivudine ブリブジン; D07249 Zostex (TN) Formula C11H13BrN2O5 CAS 69304-47-8 Mol weight 333.1353 (E)-5-(2-Bromovinyl)-2′-deoxyuridine 2M3055079H 5-[(E)-2-bromoethenyl]-2′-deoxyuridine 5-[(E)-2-Bromovinyl]-2′-deoxyuridine 6267 69304-47-8 [RN] Brivudine CAS Registry Number: 69304-47-8 CAS Name: 5-[(1E)-2-Bromoethenyl]-2¢-deoxyuridine Additional Names: (E)-5-(2-bromovinyl)-2¢-deoxyuridine; brivudin; BVDU Trademarks: Brivex (Menarini); Brivirac (Menarini); Nervinex (Menarini); Zecovir (Guidotti); Zostex (Berlin-Chemie) Molecular Formula: C11H13BrN2O5 Molecular Weight: 333.14 Percent Composition: C 39.66%, H 3.93%, Br 23.99%, N 8.41%, O 24.01% Literature References: Analog …

Sinovac COVID-19 vaccine, CoronaVac,

Sinovac COVID-19 vaccine, CoronaVac, PiCoVacc CoronaVac, also known as the Sinovac COVID-19 vaccine,[1] is an inactivated virus COVID-19 vaccine developed by the Chinese company Sinovac Biotech.[2] It has been in Phase III clinical trials in Brazil,[3] Chile,[4] Indonesia,[5] the Philippines,[6] and Turkey.[7] It relies on traditional technology similar to BBIBP-CorV and BBV152, other inactivated-virus COVID-19 vaccines in Phase III trials.[8] CoronaVac does not need to be frozen, and both the vaccine and raw material for …

Johnson & Johnson COVID-19 vaccine, JNJ 78436735

Johnson & Johnson COVID-19 vaccine, JNJ 78436735 Ad26.COV2.S JNJ-78436735 Ad26COVS1 VAC31518 UNII: JT2NS6183B https://www.onesourcedocs.com/wp-content/uploads/2021/03/Janssen_Pharmaceuticals_SDS_Ad26COVS1_100000015774_v3_5_202102_nr-1.pdf NAME DOSAGE STRENGTH ROUTE LABELLER MARKETING START MARKETING END Covid-19 Vaccine Janssen Injection, suspension 0.95 Inf. U Intramuscular Janssen Cilag International Nv 2021-03-17 Not applicable Janssen COVID-19 Vaccine Injection, suspension 50000000000 {VP}/0.5mL Intramuscular Janssen Products, LP 2021-01-04 Not applicable NAME INGREDIENTS …

NOVAWAX, NVX-CoV2373,

NOVAWAX NVX-CoV2373 SARS-CoV-2 rS Nanoparticle Vaccine MCDC OTA agreement number W15QKN-16-9-1002 Novavax COVID-19 vaccine, Coronavirus disease 19 infection SARS-CoV-2 rS, TAK 019 Novavax, Inc. is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden. As of 2020, it had an ongoing Phase III clinical trial in older adults for its candidate vaccine for seasonal influenza, NanoFlu and a candidate vaccine (NVX-CoV2373) …

BBIBP-CorV, Sinopharm COVID-19 vaccine

BBIBP-CorV, Sinopharm COVID-19 vaccine CAS Number 2503126-65-4 Inactivated novel coronavirus (2019-CoV) vaccine (Vero cells) Purified inactivated SARS-CoV-2 Vaccine ref Lancet Infectious Diseases (2021), 21(1), 39-51. BBIBP-CorV, also known as the Sinopharm COVID-19 vaccine,[1] is one of two inactivated virus COVID-19 vaccines developed by Sinopharm. In late December 2020, it was in Phase III trials in Argentina, Bahrain, Egypt, Morocco, Pakistan, Peru, and the United Arab Emirates (UAE) with over 60,000 participants.[2] On December 9, the …

Sitravatinib

Sitravatinib 1-N‘-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide 1-N’-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide MG-91516 1,1-Cyclopropanedicarboxamide, N-[3-fluoro-4-[[2-[5-[[(2-methoxyethyl)amino]methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxy]phenyl]-N’-(4- fluorophenyl)- N-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide シトラバチニブ; ситраватиниб , سيترافاتينيب , 司曲替尼 , Formula C33H29F2N5O4S Cas 1123837-84-2 Mol weight 629.6763 MG-516 Sitravatinib (MGCD516) UNII-CWG62Q1VTB CWG62Q1VTB MGCD-516 MGCD516 Antineoplastic, Receptor tyrosine kinase inhibitor Sitravatinib (MGCD516) is an experimental drug for the treatment of cancer. It is a small molecule inhibitor of multiple tyrosine kinases. Sitravatinib is being developed by Mirati Therapeutics.[1] Ongoing phase II …

Anamorelin hydrochloride

Anamorelin 249921-19-5 [RN] 3-{(2R)-3-{(3R)-3-Benzyl-3-[(trimethylhydrazino)carbonyl]-1-piperidinyl}-2-[(2-methylalanyl)amino]-3-oxopropyl}-1H-indole 3-Piperidinecarboxylic acid, 1-[(2R)-2-[(2-amino-2-methyl-1-oxopropyl)amino]-3-(1H-indol-3-yl)-1-oxopropyl]-3-(phenylmethyl)-, 1,2,2-trimethylhydrazide, (3R)- 8846 анаморелин أناموريلين 阿那瑞林 Formula C31H42N6O3 Molar mass 546.716 g·mol−1 .HCL Anamorelin hydrochloride 3-Piperidinecarboxylic acid, 1-[(2R)-2-[(2-amino-2-methyl-1-oxopropyl)amino]-3-(1H-indol-3-yl)-1-oxopropyl]-3-(phenylmethyl)-, 1,2,2- trimethylhydrazide, hydrochloride (1:1), (3R)- Formula C31H42N6O3. HCl CAS 861998-00-7 Mol weight 583.1645 APPROVED JAPAN PMDA Adlumiz, 22/1/2021 アナモレリン塩酸塩 ONO-7643, RC-1291, ST-1291 Antineoplastic, Growth hormone secretagogue receptor (GHSR) agonist Anamorelin is a non-peptidic ghrelin mimetic Treatment …

DASATINIB

DASATINIB ダサチニブ水和物 BMS 354825 863127-77-9 HYDRATE, USAN, BAN INN, JAN UNII: RBZ1571X5H 302962-49-8 FREE FORM Dasatinib anhydrous USAN, INN Molecular Formula, C22-H26-Cl-N7-O2-S.H2-O, Molecular Weight, 506.0282 T6N DNTJ A2Q D- DT6N CNJ B1 FM- BT5N CSJ DVMR BG F1 [WLN] X78UG0A0RN дазатиниб [Russian] [INN] دازاتينيب [Arabic] [INN] 达沙替尼 [Chinese] [INN] 1132093-70-9 [RN] 302962-49-8 [RN] 5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]- 8712 9966762 [Beilstein] A pyrimidine and thiazole derived ANTINEOPLASTIC AGENT and PROTEIN KINASE …

Norepinephrine bitartrate

Norepinephrine bitartrate Arterenol bitartrate RN: 3414-63-9 FREE FORM 138-65-8 UNIIIFY5PE3ZRW R FORM CAS Number108341-18-0, 1,2-Benzenediol, 4-(2-amino-1-hydroxyethyl)-, (R)-, [R-(R*,R*)]-2,3-dihydroxybutanedioate (1:1) (salt), monohydrate 1,2-Benzenediol, 4-[(1R)-2-amino-1-hydroxyethyl]-, (2R,3R)-2,3-dihydroxybutanedioate (1:1) (salt), monohydrate (9CI) Arterenol, tartrate, monohydrate (6CI) L-Noradrenaline bitartrate monohydrate Levarterenol bitartrate monohydrate WeightAverage: 337.281 Chemical FormulaC12H19NO10 (+-)-Arterenol bitartrate (+-)-Noradrenaline bitartrate (+-)-Norepinephrine bitartrate (2R,3R)-2,3-dihydroxybutanedioic acid 4-[(1R)-2-amino-1-hydroxyethyl]benzene-1,2-diol hydrate ORD +41.3 °, water, 4% ; Wavlen: …

COVAXIN, BBV 152

COVAXIN CAS 2501889-19-4 Whole-Virion Inactivated SARS-CoV-2 Vaccine UNII76JZE5DSN6 BBV 152 A whole virion inactivated COVID-19 vaccine candidate derived from SARS-CoV-2 strain NIV-2020-770 REF medRxiv (2020), 1-21. bioRxiv (2020), 1-32. BBV152 (also known as Covaxin) is an inactivated virus-based COVID-19 vaccine being developed by Bharat Biotech in collaboration with the Indian Council of Medical Research. BBV152 is a vaccine candidate created by the Indian Council of Medical Research (ICMR). …